Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- ChecktodayChange DetectedVersion 2 (2021-10-12) updated the recruitment status for the study NCT04407988 in the record history.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check29 days agoChange DetectedVersion updated from v3.0.2 to v3.2.0; no substantive content changes detected.SummaryDifference0.3%

- Check30 days agoChange DetectedUpdate to a newer revision tag (from v3.0.2 to v3.1.0); no substantive changes to core content or user-facing data.SummaryDifference0.3%

- Check45 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, signaling a new release. The 'Back to Top' UI element was removed, a minor change.SummaryDifference0.8%

- Check52 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.SummaryDifference0.8%

- Check59 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference5%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.